Compare ACOG & STEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ACOG | STEX |
|---|---|---|
| Founded | 2000 | 2009 |
| Country | Canada | United States |
| Employees | 57 | 6 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.4M | 99.7M |
| IPO Year | N/A | N/A |
| Metric | ACOG | STEX |
|---|---|---|
| Price | $6.10 | $0.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $16.00 | $9.00 |
| AVG Volume (30 Days) | 38.5K | ★ 1.5M |
| Earning Date | 05-14-2026 | 05-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $139.22 | N/A |
| Revenue Next Year | $134.48 | $1,044.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.50 | $0.70 |
| 52 Week High | $10.88 | $7.44 |
| Indicator | ACOG | STEX |
|---|---|---|
| Relative Strength Index (RSI) | 46.61 | 43.06 |
| Support Level | $5.00 | $0.70 |
| Resistance Level | $6.59 | $1.16 |
| Average True Range (ATR) | 0.42 | 0.15 |
| MACD | -0.07 | 0.03 |
| Stochastic Oscillator | 28.62 | 42.35 |
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Streamex Corp is a vertically integrated technology and infrastructure company. The Company is a technology company with two principal lines of business: (i) Tokenized Asset Finance, focused on digital asset and real-world asset tokenization via Streamex Exchange platform, and (ii) Biomedical Technology, focused on signal processing solutions in electrophysiology. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.